582 related articles for article (PubMed ID: 33111959)
1. Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas.
Ma B; Li H; Qiao J; Meng T; Yu R
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33111959
[TBL] [Abstract][Full Text] [Related]
2. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
3. A novel comprehensive immune-related gene signature as a promising survival predictor for the patients with head and neck squamous cell carcinoma.
Fang R; Iqbal M; Chen L; Liao J; Luo J; Wei F; Wen W; Sun W
Aging (Albany NY); 2021 Apr; 13(8):11507-11527. PubMed ID: 33867351
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma.
He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H
Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150
[TBL] [Abstract][Full Text] [Related]
5. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
Zhao X; Cui L
J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519
[TBL] [Abstract][Full Text] [Related]
6. Identification novel prognostic signatures for Head and Neck Squamous Cell Carcinoma based on ceRNA network construction and immune infiltration analysis.
Zhou H; He Y; Li L; Wu C; Hu G
Int J Med Sci; 2021; 18(5):1297-1311. PubMed ID: 33526991
[No Abstract] [Full Text] [Related]
7. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
9. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
10. Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma.
Chen Y; Nie J; Li X; Fan T; Deng X; Liang D; Song G
J Immunol Res; 2021; 2021():6661625. PubMed ID: 33506058
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory response-related genes predict prognosis in patients with HNSCC.
Jing SL; Afshari K; Guo ZC
Immunol Lett; 2023 Jul; 259():46-60. PubMed ID: 37279805
[TBL] [Abstract][Full Text] [Related]
12. An immune-related seven-lncRNA signature for head and neck squamous cell carcinoma.
Chen Y; Luo TQ; Xu SS; Chen CY; Sun Y; Lin L; Mao YP
Cancer Med; 2021 Apr; 10(7):2268-2285. PubMed ID: 33660378
[TBL] [Abstract][Full Text] [Related]
13. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma.
Mao R; Chen Y; Xiong L; Liu Y; Zhang T
Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
Zhang J; Zhong X; Jiang H; Jiang H; Xie T; Tian Y; Li R; Wang B; Zhang J; Yuan Y
Aging (Albany NY); 2020 Nov; 12(22):22509-22526. PubMed ID: 33216727
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma.
Yang C; Mei H; Peng L; Jiang F; Xie B; Li J
Comput Math Methods Med; 2020; 2020():7397132. PubMed ID: 33456497
[TBL] [Abstract][Full Text] [Related]
16. Construction of an m6A-related lncRNA pair prognostic signature and prediction of the immune landscape in head and neck squamous cell carcinoma.
Zhou C; Wang S; Shen Z; Shen Y; Li Q; Shen Y; Huang J; Deng H; Ye D; Zhan G; Li J
J Clin Lab Anal; 2022 Jan; 36(1):e24113. PubMed ID: 34783061
[TBL] [Abstract][Full Text] [Related]
17. Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients.
Huang Y; Liu Z; Zhong L; Wen Y; Ye Q; Cao D; Li P; Liu Y
BMC Genomics; 2020 Oct; 21(1):691. PubMed ID: 33023466
[TBL] [Abstract][Full Text] [Related]
18. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma.
Chen L; Cai Z; Lyu K; Cai Z; Lei W
Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440
[TBL] [Abstract][Full Text] [Related]
19. Deciphering a Prognostic Signature Based on Soluble Mediators Defines the Immune Landscape and Predicts Prognosis in HNSCC.
Chi H; Peng G; Song G; Zhang J; Xie X; Yang J; Xu J; Zhang J; Xu K; Wu Q; Yang G
Front Biosci (Landmark Ed); 2024 Mar; 29(3):130. PubMed ID: 38538268
[TBL] [Abstract][Full Text] [Related]
20. A Signature of N
Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
Front Immunol; 2022; 13():809872. PubMed ID: 35185897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
